Novel technology in fixed-dose combinations – Unigel™:

Unigel™ (US Patent No. 8,967,989B2) is a first-to-market technology designed to combine multiple active pharmaceutical ingredient (API) formulations in one single soft gelatin capsule, offering multi-phase therapies, improving bioavailability, reducing manufacturing costs, and achieving superior adherence to different therapies.

Unigel™ (US Patent No. 8,967,989B2) is a first-to-market technology designed to combine multiple active pharmaceutical ingredient (API) formulations in one single soft gelatin capsule, offering multi-phase therapies, improving bioavailability, reducing manufacturing costs, and achieving superior adherence to different therapies.

Unigel™ technology provides various forms for fixed-dose combinations, such as a softgel in a softgel, a tablet in a softgel, granules in a softgel, or any combination to address challenges of multi-active formulation, offering unique prescription, over-the-counter (OTC) and OTX products.